Translational Program in Cancer Research (CARE)

Scope and aim

The program's research focuses on various forms of cancer, with the goal of accelerating the transfer of cutting-edge knowledge and technological progress in the diagnosis, treatment, and prevention of cancer. Through this program, the quality of cancer research will be enhanced and its impact in clinical practice will be maximised. The CARE Program has several scientific and functional aims that are designed to: 

  • Promote the development and implementation of precision and personalised medicine.
  • Advance basic and translational research towards innovation and technology transfer.
  • Establish a collaborative and transversal network of clinical, translational and basic researchers.
  • Implement an efficient working framework among researchers to increase research impact.
  • Enable advanced computational tools in translational research practices.

Structure of the program


  • Core members: IGTP / HUGTiP / ICO.
  • Associate institutions: IJC, IrsiCaixa, UAB.

Executive Committee:

  • Directors: Mireia Margelí (Clinical research), Miguel A Peinado (Basic research).
  • Sections' coordinators: Anna Martínez-Cardús (Networking), Eduard Serra (Scientific), Arola Fortian (Training & Communication).

2023 highlights

In 2023, the CARE Program made significant strides in enhancing cancer research and its application in clinical settings.

The program continued to organise seminars, courses and meetings, while also participating in outreach activities.

  • 3 internal presentations
  • 7 courses and scientific meetings
  • 18 CARE Translational Seminars in Cancer Research
  • 1 symposium
  • 3 outreach activities


As a new development, the program created focused nodes on translational cancer research:

  • Preclinical models
  • Immunology / Immunotherapy
  • Tumour heterogeneity & liquid biopsy

Research groups